胎児の神経保護を目的とした妊婦に対するクレアチン
Referencias
Additional references
Australian Cerebral Palsy Register (ACPR) Group. Report of the Australian Cerebral Palsy Register, Birth Years 1993‐2003. Cerebral Palsy Institute, 2009.
ACTRN12612000858897. Melatonin to prevent brain injury in unborn growth restricted babies (MEL). https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=362854 (accessed 10 December 2013).
Adcock KH, Nedelcu J, Loenneker T, Martin E, Wallimann T, Wagner BP. Neuroprotection of creatine supplementation in neonatal rats with transient cerebral hypoxia‐ischemia. Developmental Neuroscience 2002;24(5):382‐8.
Bain ES, Middleton PF, Crowther CA. Maternal adverse effects of different antenatal magnesium sulphate regimens for improving maternal and infant outcomes: a systematic review. BMC Pregnancy and Childbirth 2013;13:195.
Bax M, Goldstein M, Rosenbaum P, Leviton A, Paneth N, Dan B, et al. Proposed definition and classification of cerebral palsy. Developmental Medicine and Child Neurology 2005;47:571‐6.
Beal M. Neuroprotective effects of creatine. Amino Acids 2011;40(5):1305‐13.
Bender A, Auer DP, Merl T, Reilmann R, Saemann P, Yassouridis A, et al. Creatine supplementation lowers brain glutamate levels in Huntington's disease. Journal of Neurology 2005;252(1):36‐41.
Bender A, Koch W, Elstner M, Schombacher Y, Bender J, Moeschl M. Creatine supplementation in Parkinson disease: a placebo‐controlled randomized pilot trial. Neurology 2006;67(7):1262‐4.
Blair E, Watson L. Epidemiology of cerebral palsy. Seminars in Fetal and Neonatal Medicine 2006;11:117‐23.
Braissant O, Henry H, Villard AM, Speer O, Wallimann T, Bachmann C. Creatine synthesis and transport during rat embryogenesis: spatiotemporal expression of AGAT, GAMT and CT1. BMC Developmental Biology 2005;5:9.
Calvert, JW, Zhang JH. Pathophysiology of an hypoxic–ischemic insult during the perinatal period. Neurological Research 2005;27(3):246‐60.
Cannata DJ, Ireland Z, Dickinson H, Snow RJ, Russell AP, West JM, et al. Maternal creatine supplementation from mid‐pregnancy protects the diaphragm of the newborn spiny mouse from intrapartum hypoxia‐induced damage. Pediatric Research 2010;68(5):393‐8.
Dickinson H, Ireland ZJ, Larosa DA, O'Connell BA, Ellery S, Snow R, et al. Maternal dietary creatine supplementation does not alter the capacity for creatine synthesis in the newborn spiny mouse. Reproductive Sciences 2013;20(9):1096‐102.
Dickinson H, Ellery S, Ireland Z, Larosa D, Snow R, Walker DW. Creatine supplementation during pregnancy: summary of experimental studies suggesting a treatment to improve fetal and neonatal morbidity and reduce mortality in high‐risk human pregnancy. BMC Pregnancy and Childbirth 2014;14:150.
Dilenge M, Majnemer A, Shevell M. Long‐term developmental outcome of asphyxiated term neonates. Journal of Child Neurology 2001;16:781‐92.
Doyle LW, Crowther CA, Middleton P, Marret S, Rouse D. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database of Systematic Reviews 2009, Issue 1. [DOI: 10.1002/14651858.CD004661.pub3]
du Plessis AJ, Volpe JJ. Perinatal brain injury in the preterm and term newborn. Current Opinion in Neurology 2002;15:151‐7.
Ellery SJ, Ireland Z, Kett MM, Snow R, Walker DW, Dickinson H. Creatine pretreatment prevents birth asphyxia‐induced injury of the newborn spiny mouse kidney. Pediatric Research 2013;73(2):201‐8.
Gates S, Brocklehurst P. How should trials recruiting women with multiple pregnancies be analysed?. British Journal of Obstetrics and Gynaecology 2004;111:213‐9.
Gualano B, de Salles Painelli V, Roschel H, Lugaresi R, Dorea E, Artioli GG. Creatine supplementation does not impair kidney function in type 2 diabetic patients: a randomized, double‐blind, placebo‐controlled, clinical trial. European Journal of Applied Physiology 2011;111(5):749‐56.
Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.
Hobson SR, Lim R, Gardiner EE, Alers NO, Wallace EM. Phase I pilot clinical trial of antenatal maternally administered melatonin to decrease the level of oxidative stress in human pregnancies affected by pre‐eclampsia (PAMPR): study protocol. BMJ Open 2013;3:e003788.
Ireland Z, Dickinson H, Snow R, Walker DW. Maternal creatine: does it reach the fetus and improve survival after an acute hypoxic episode in the spiny mouse (Acomys cahirinus)?. American Journal of Obstetrics and Gynecology 2008;198(4):431e1‐6.
Ireland Z, Castillo‐Melendez M, Dickinson H, Snow R, Walker DW. A maternal diet supplemented with creatine from mid‐pregnancy protects the newborn spiny mouse brain from birth hypoxia. Neuroscience 2011;194:372‐9.
Jacobsson B, Hagberg G, Hagberg B, Ladfors L, Niklasson A, Hagberg H. Cerebral palsy in preterm infants: a population‐based case‐control study of antenatal and intrapartal risk factors. Acta Paediatrica 2002;91:946‐51.
Jensen A, Garnier Y, Middelanis J, Berger R. Perinatal brain damage—from pathophysiology to prevention. European Journal of Obstetrics, Gynecology, and Reproductive Biology 2003;110:S70‐9.
Johnston MV, Trescher WH, Ishida A, Nakajima W. Novel treatments after experimental brain injury. Seminars in Neonatology 2000;5:75‐86.
Kaandorp JJ, Benders MJ, Rademaker CM, Torrance HL, Oudijk MA, de Haan TR, et al. Antenatal allopurinol for reduction of birth asphyxia induced brain damage (ALLO‐Trial); a randomized double blind placebo controlled multicenter study. BMC Pregnancy and Childbirth 2010;10:8.
Kaandorp JJ, van Bel F, Veen S, Derks JB, Groenendaal F, Rijken M, et al. Long‐term neuroprotective effects of allopurinol after moderate perinatal asphyxia: follow‐up of two randomised controlled trials. Archives of Disease in Childhood. Fetal and Neonatal Edition 2012;97(3):F162‐166.
Kane AD, Hansell JA, Herrera EA, Allison BJ, Niu Y, Brain KL, et al. Xanthine oxidase and the fetal cardiovascular defence to hypoxia in late gestation ovine pregnancy. Journal of Physiology 2014;592(Pt 3):4765‐89.
Larroque B, Marret S, Ancel PY, Arnaud C, Marpeau L, Supernant K, et al. White matter damage and intraventricular hemorrhage in very preterm infants: the EPIPAGE study. Journal of Pediatrics 2003;143(4):477‐83.
Lawler JM, Barnes WS, Wu G, Song W, Demaree S. Direct antioxidant properties of creatine. Biochemical and Biophysical Research Communications 2002;290(1):47‐52.
Marret S, Doyle LW, Crowther CA, Middleton P. Antenatal magnesium sulphate neuroprotection in the preterm infant. Seminars in Fetal & Neonatal Medicine 2007;12(4):311‐7.
McIntyre S, Taitz D, Keogh J, Goldsmith S, Badawi N, Blair E. A systematic review of risk factors for cerebral palsy in children born at term in developed countries. Developmental Medicine and Child Neurology 2013;55:499‐508.
Miller R, Davis BM, Brent RL, Koszalka TR. Transport of creatine in the human placenta. Pharmacologist 1974;16(2):305.
Nguyen TMN, Crowther CA, Wilkinson D, Bain E. Magnesium sulphate for women at term for neuroprotection of the fetus. Cochrane Database of Systematic Reviews 2013, Issue 2. [DOI: 10.1002/14651858.CD009395.pub2]
Novak I, Hines M, Goldsmith S, Barclay R. Clinical prognostic messages from a systematic review of cerebral palsy. Paediatrics 2012;130(5):e1285‐312.
Pastula DM, Moore DH, Bedlack RS. Creatine for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database of Systematic Reviews 2012, Issue 12. [DOI: 10.1002/14651858.CD005225.pub3]
Prass K, Royl G, Lindauer U, Freyer D, Megow D, Dirnagl U, et al. Improved reperfusion and neuroprotection by creatine in a mouse model of stroke. Journal of Cerebral Blood Flow and Metabolism 2006;27(3):452‐9.
Rees S, Harding R, Walker D. The biological basis of injury and neuroprotection in the fetal and neonatal brain. International Journal of Developmental Neuroscience 2011;29(6):551–63.
The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database of Systematic Reviews 2006, Issue 3. [DOI: 10.1002/14651858.CD004454.pub2]
Sakellaris G, Kotsiou M, Tamiolaki M, Kalostos G, Tsapaki E, Spanaki M, et al. Prevention of complications related to traumatic brain injury in children and adolescents with creatine administration: an open label randomized pilot study. Journal of Trauma 2006;61(2):322‐9.
Sakellaris G, Nasis G, Kotsiou M, Tamiolaki M, Charissis G, Evangeliou A. Prevention of traumatic headache, dizziness and fatigue with creatine administration. A pilot study. Acta Paediatrica 2008;97(1):31‐4.
Sestili P, Martinelli C, Bravi G, Piccoli G, Curci R, Battistelli M, et al. Creatine supplementation affords cytoprotection in oxidatively injured cultured mammalian cells via direct antioxidant activity. Free Radical Biology and Medicine 2006;40(5):837‐49.
Sullivan PG, Geiger JD, Mattson MP, Scheff SW. Dietary supplement creatine protects against traumatic brain injury. Annals of Neurology 2000;48(5):723‐9.
Volpe JJ. Perinatal brain injury: from pathogenesis to neuroprotection. Mental Retardation and Developmental Disabilities 2001;7:56‐64.
Wallimann TWM, Brdiczka D, Nicolay K, Eppenberger H. Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the “phosphocreatine circuit” for cellular energy homeostasis. Biochemical Journal 1992;281(Pt 1):21‐40.
Wallimann T, Tokarska‐Schlattner M, Schlattner U. The creatine kinase system and pleiotropic effects of creatine. Amino Acids 2011;40(5):1271‐96.
Wang J, Xiao Y, Chen S, Zhong C, Luo M, Luo H. Creatine for Parkinson's disease. Cochrane Database of Systematic Reviews 2012, Issue 2. [DOI: 10.1002/14651858.CD009646]
Wilkinson D, Bain E, Wallace E. Melatonin for women in pregnancy for neuroprotection of the fetus. Cochrane Database of Systematic Reviews 2013, Issue 5. [DOI: 10.1002/14651858.CD010527]
Wu Y, Escobar G, Grether J, Croen L, Greene J, Newman T. Chorioamnionitis and cerebral palsy in term and near‐term infants. JAMA 2003;290(20):2677‐84.
Wyss M, Schulze A. Health implications of creatine: can oral creatine supplementation protect against neurological and atherosclerotic disease?. Neuroscience 2002;112(2):243‐60.
Zhu S, Li M, Figueroa BE, Liu A, Stavrovskaya IG, Pasinelli P, et al. Prophylactic creatine administration mediates neuroprotection in cerebral ischemia in mice. Journal of Neuroscience 2004;24(26):5909‐12.
